| [1] |
蒋冬, 杨旭, 帅旭. 卵巢癌患者腹腔镜术后外周血IL-37、HK10、SMRP水平监测意义研究[J]. 中国性科学, 2024, 33(1):98-102.
|
| [2] |
董延华, 张彩丽, 樊荣, 等. 腹腔镜根治术对卵巢癌患者生活质量、并发症发生情况及预后的影响[J]. 癌症进展, 2023, 21(23):2621-2624.
|
| [3] |
VITO ANDREA C, UCCELLA S, SOZZI G, et al. Primary site disease and recurrence location in ovarian cancer patients undergoing primary debulking surgery vs. interval debulking surgery[J]. Eur J Surg Oncol, 2021, 47(5):1075-1082.
DOI
PMID
|
| [4] |
KAN T, ZHANG S, ZHOU S, et al. Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence[J]. Oncogene, 2022, 41(6):895-906.
DOI
PMID
|
| [5] |
XIAO D, XIONG M, WANG X, et al. Regulation of the function and expression of EpCAM[J]. Biomedicines, 2024, 12(5):1129.
DOI
URL
|
| [6] |
SÜER H, ERUS S, CESUR E E, et al. Combination of CEACAM5,EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer[J]. J Cardiothorac Surg, 2023, 18(1):189.
DOI
|
| [7] |
AZNAB M, SHAHHOSSEINI R, SAFAEI M, et al. Salivary and serum levels of soluble E-cadherin in patients with gastrointestinal cancers:a comparative study[J]. J Cancer Res Ther, 2023, 19(7):1982-1987.
DOI
URL
|
| [8] |
FU M, ZHANG J, ZHANG L, et al. Cell cycle-related FAM64A could be activated by TGF-β signaling to promote glioma progression[J]. Cell Mol Neurobiol, 2023, 43(6):2975-2987.
DOI
PMID
|
| [9] |
卵巢癌诊疗规范(2018年版)[J]. 肿瘤综合治疗电子杂志, 2019, 5(2):87-96.
|
| [10] |
AKTER S, RAHMAN M A, HASAN M N, et al. Recent advances in ovarian cancer:therapeutic strategies,potential biomarkers,and technological improvements[J]. Cells, 2022, 11(4):650.
DOI
URL
|
| [11] |
LIU S, WU M, WANG F. Research progress in prognostic factors and biomarkers of ovarian cancer[J]. J Cancer, 2021, 12(13):3976-3996.
DOI
PMID
|
| [12] |
LI D, GUO X, YANG K, et al. EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors[J]. Sci Adv, 2023, 9(48):eadg9721.
|
| [13] |
JIANG X, WANG S, LIANG Q, et al. Unraveling the multifaceted role of EpCAM in colorectal cancer:an integrated review of its function and interplay with non-coding RNAs[J]. Med Oncol, 2023, 41(1):35.
DOI
|
| [14] |
IBRAHIM H M, ABDELRAHMAN A E, ELSEBAI E, et al. Clinicopathologic impact of NANOG,ZEB1,and EpCAM biomarkers on prognosis of serous ovarian carcinoma[J]. Asian Pac J Cancer Prev, 2023, 24(9):3247-3259.
DOI
URL
|
| [15] |
CHEN W, YE S, WANG X, et al. Soluble E-cadherin promotes invasiveness of neoplastic cells in salivary gland carcinoma ex pleomorphic adenoma[J]. J Oral Pathol Med, 2023, 52(1):63-71.
DOI
URL
|
| [16] |
PAWAR N R, BUZZA M S, DURU N, et al. Matriptase drives dissemination of ovarian cancer spheroids by a PAR-2/PI3K/Akt/MMP9 signaling axis[J]. J Cell Biol, 2023, 222(11):e202209114.
DOI
URL
|
| [17] |
HU Q P, KUANG J Y, YANG Q K, et al. Beyond a tumor suppressor:soluble E-cadherin promotes the progression of cancer[J]. Int J Cancer, 2016, 138(12):2804-2812.
DOI
URL
|
| [18] |
何旻, 巢琳, 华亦汇. 乳腺癌改良根治术后血清sE-Cad、s-CD105水平与复发转移的相关性分析[J]. 中国现代医学杂志, 2024, 34(5):95-100.
|
| [19] |
庞倩, 蒙绪君, 肖钦晓. 基于数据挖掘分析FAM64A在肺腺癌中的表达模式和作用机制[J]. 东南大学学报(医学版), 2022, 41(5):629-636.
|
| [20] |
ZHAO X, CHEN H, QIU Y, et al. FAM64A promotes HNSCC tumorigenesis by mediating transcriptional autoregulation of FOXM1[J]. Int J Oral Sci, 2022, 14(1):25.
DOI
|
| [21] |
SHINDEN Y, HIRASHIMA T, NOHATA N, et al. Molecular pathogenesis of breast cancer:impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes[J]. J Hum Genet, 2021, 66(5):519-534.
DOI
|
| [22] |
ZHENG H C, REN D H, ZHANG C Y, et al. A bioinformatics analysis of the clinicopathological and prognostic significance of FAM64A mRNA expression in gynecological cancers[J]. J Obstet Gynaecol, 2023, 43(1):2216280.
DOI
URL
|
| [23] |
姚卓城. FAM64A通过调节细胞增殖与迁移参与乳腺癌的发生发展[D]. 广州: 南方医科大学, 2019.
|
| [24] |
西尔艾力·吾门尔, 赵艳萍. 18F-FDG PET/CT显像联合CA125及HE4在上皮性卵巢癌患者术后复发/转移诊断中的价值[J]. 分子影像学杂志, 2020, 43(1):70-75.
|